Natco Pharma Ltd.

Natco Pharma is currently trading at Rs. 625.00, up by 1.20 points or 0.19% from its previous closing of Rs. 623.80 on the BSE.

The scrip opened at Rs. 624.25 and has touched a high and low of Rs. 629.90 and Rs. 624.25 respectively. So far 356 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 650.00 on 16-Aug-2013 and a 52 week low of Rs. 367.90 on 31-Oct-2012.

Last one week high and low of the scrip stood at Rs. 640.70 and Rs. 610.00 respectively. The current market cap of the company is Rs. 1963.95 crore.

The promoters holding in the company stood at 56.63% while Institutions and Non-Institutions held 20.81% and 22.57% respectively.

In a bid to set up a pre-filled syringe unit, Natco Pharma is planning to raise around Rs 150 crore by end of next month. The proposed unit will be coming up at Kothur in Mahbubnagar district of Andhra Pradesh.

The company, on September 28, received its shareholders’ approval to mobile funds through a variety of instruments, including qualified institutions placements, fully or partly convertible debentures, non-convertible debentures with warrants and foreign currency convertible bonds.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.